- Read our full report in PDF format here.
- Browse our report website here.
Message from PFSCM’s Chief Operating Officer
Reflecting on 2024, we are proud to share our organization’s remarkable achievements. This past year was marked by strategic growth, operational advancements, and a reinforced commitment to our mission of improving global health outcomes.
We successfully maintained our ISO 9001:2015 Quality Management System and advanced to full compliance with the ISO 20400:2017 Sustainable Procurement standard, a testament to our dedication to excellence and responsible sourcing. Further, we expanded our impact by welcoming two new clients focused on antimicrobial resistance surveillance and child mortality prevention.
A significant milestone was our entry into key global health networks, including the Integrated Diagnostics Consortium and Secure. These partnerships enhance our ability to stay ahead of industry trends and collaborate on innovative health solutions.
Operationally, we diversified our product portfolio to include mpox, Ebola, and antimicrobial products. We also upgraded our ERP system and launched a digital portal for requisition and catalog management, streamlining procurement processes for our partners. Moreover, we established new teams and initiated several Operational Excellence projects to drive efficiency and effectiveness.
In 2024, we processed thousands of purchase orders valued at more than $488 million, supplying more than 58.5 million malaria and 27 million HIV rapid diagnostic tests, along with nearly four million HIV self-test kits. These extensive procurement efforts make diagnostic testing more accessible globally.
Beyond volume, the complexity of our orders increased, with specialized projects such as next-generation sequencing equipment, medical imaging systems, and waste management solutions requiring extensive collaboration with end users. Our consultative approach to executing these projects has significantly mitigated supply chain risks and enhanced service delivery.
With 2,404 shipments spanning more than 12 million units across 86 countries, we ensured the timely delivery of critical healthcare products. Our reach extended to high-need areas, including Malawi, Uganda, the Democratic Republic of the Congo, Nigeria, and several others. Notable deliveries included CT scanners for Mozambique, X-ray systems for Pakistan, and essential HIV and tuberculosis products for Nigeria, Laos, and Mali.
Our success in 2024 was driven by the dedication of our talented team, the strength of our partnerships, and our commitment to improving healthcare access. As we move forward, we will continue to build on this momentum, striving for even greater impact in 2025 and beyond.
- Read our full report in PDF format here.
- Browse our report website here.
